Plugging gaps in China’s hepatitis B prevention would be cost effective

BMJ 2009; 339 doi: 10.1136/bmj.b4420 (Published 28 October 2009)
Cite this as: BMJ 2009;339:b4420

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jane Parry
  1. 1Hong Kong

    A country-wide catch-up hepatitis B vaccination programme in China would save thousands of lives and be cost effective, research from Stanford University has shown (Hepatology 2009 Sep 9, doi:10.1002/hep.23310).

    Vaccinating the estimated 150 million children aged 1-19 years who are currently unprotected will cost an estimated $423m (£260m; €281m) but will save the economy $840m, by preventing eight million infections and 65 000 deaths, the researchers found.

    Routine free vaccination of babies against the disease began only in 2002, and serological survey data show that 40% of children …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL